Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000020EBVENSG00000122420.10protein_codingPTGFRNoNo5737P43088
TVIS42000021EBVENSG00000122420.10protein_codingPTGFRNoNo5737P43088
TVIS10032691HBVENSG00000122420.10protein_codingPTGFRNoNo5737P43088
TVIS20002754HPVENSG00000122420.10protein_codingPTGFRNoNo5737P43088
TVIS20010565HPVENSG00000122420.10protein_codingPTGFRNoNo5737P43088
TVIS20011236HPVENSG00000122420.10protein_codingPTGFRNoNo5737P43088
TVIS20048401HPVENSG00000122420.10protein_codingPTGFRNoNo5737P43088
TVIS20048060HPVENSG00000122420.10protein_codingPTGFRNoNo5737P43088
TVIS20047883HPVENSG00000122420.10protein_codingPTGFRNoNo5737P43088
TVIS20047818HPVENSG00000122420.10protein_codingPTGFRNoNo5737P43088
TCGA Plot Options
Drug Information
GenePTGFR
DrugBank IDDB08819
Drug NameTafluprost
Target IDBE0000610
UniProt IDP43088
Regulation Typeagonist
PubMed IDs21858491
CitationsPantcheva MB, Seibold LK, Awadallah NS, Kahook MY: Tafluprost: a novel prostaglandin analog for treatment of glaucoma. Adv Ther. 2011 Sep;28(9):707-15. doi: 10.1007/s12325-011-0055-8. Epub 2011 Aug 18.
GroupsApproved
Direct ClassificationProstaglandins and related compounds
SMILESCC(C)OC(=O)CCCC=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1C=CC(F)(F)COC1=CC=CC=C1
Pathways
PharmGKBPA165958432
ChEMBLCHEMBL1963683